Phase 2 Dose-Finding Study Evaluating the Efficacy and Safety of EDP167 in Adults With Mixed Dyslipidemia

A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 144 participants.

Also called NCT07799129

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 144 participants (planned count) (from the registry)
Sponsor
Eddingpharm (Zhuhai) Co., Ltd. (from the registry)
Registry
  • NCT NCT07799129
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07799129. Randomized; double masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2027-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Phase 2 Dose-Finding Study Evaluating the Efficacy and Safety of EDP167 in Adults With Mixed Dyslipidemia
Condition
Mixed Dyslipidemia
Intervention (Drug)
EDP167 100mg
Intervention (Drug)
EDP167 200mg
Intervention (Drug)
EDP167 300mg
Lead sponsor
Eddingpharm (Zhuhai) Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct07799129
Content hash
3df89ad65ef3e2ed5a72298e734280e146513591deecf8347f0644e8f3038812